Abstract
Pharmacotherapy is effective in decreasing the incidence of osteoporotic fracture, morbidity, and mortality. This benefit is pronounced in patients at highest risk for fracture: those with prior osteoporotic fracture, very low bone mineral density, or receiving chronic corticosteroid treatment. We review the best pharmacotherapeutic options currently available for treating osteoporosis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 118-123 |
| Number of pages | 6 |
| Journal | Missouri medicine |
| Volume | 108 |
| Issue number | 2 |
| State | Published - Mar 2011 |
ASJC Scopus subject areas
- General Medicine